Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial
- PMID: 25764091
- DOI: 10.1007/s00330-015-3689-0
Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial
Abstract
Objectives: Lung cancer risk models should be externally validated to test generalizability and clinical usefulness. The Danish Lung Cancer Screening Trial (DLCST) is a population-based prospective cohort study, used to assess the discriminative performances of the PanCan models.
Methods: From the DLCST database, 1,152 nodules from 718 participants were included. Parsimonious and full PanCan risk prediction models were applied to DLCST data, and also coefficients of the model were recalculated using DLCST data. Receiver operating characteristics (ROC) curves and area under the curve (AUC) were used to evaluate risk discrimination.
Results: AUCs of 0.826-0.870 were found for DLCST data based on PanCan risk prediction models. In the DLCST, age and family history were significant predictors (p = 0.001 and p = 0.013). Female sex was not confirmed to be associated with higher risk of lung cancer; in fact opposing effects of sex were observed in the two cohorts. Thus, female sex appeared to lower the risk (p = 0.047 and p = 0.040) in the DLCST.
Conclusions: High risk discrimination was validated in the DLCST cohort, mainly determined by nodule size. Age and family history of lung cancer were significant predictors and could be included in the parsimonious model. Sex appears to be a less useful predictor.
Key points: • High accuracy in logistic modelling for lung cancer risk stratification of nodules. • Lung cancer risk prediction is primarily based on size of pulmonary nodules. • Nodule spiculation, age and family history of lung cancer are significant predictors. • Sex does not appear to be a useful risk predictor.
Trial registration: ClinicalTrials.gov NCT00496977.
Similar articles
-
Prior CT Improves Deep Learning for Malignancy Risk Estimation of Screening-detected Pulmonary Nodules.Radiology. 2023 Aug;308(2):e223308. doi: 10.1148/radiol.223308. Radiology. 2023. PMID: 37526548
-
Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.JAMA Netw Open. 2020 Feb 5;3(2):e1921221. doi: 10.1001/jamanetworkopen.2019.21221. JAMA Netw Open. 2020. PMID: 32058555
-
Risk stratification for lung nodules: Size isn't everything.J Thorac Cardiovasc Surg. 2017 Jun;153(6):1557-1562. doi: 10.1016/j.jtcvs.2016.12.068. Epub 2017 Feb 16. J Thorac Cardiovasc Surg. 2017. PMID: 28314535 Review. No abstract available.
-
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.Eur Radiol. 2017 Oct;27(10):4019-4029. doi: 10.1007/s00330-017-4767-2. Epub 2017 Mar 14. Eur Radiol. 2017. PMID: 28293773 Free PMC article.
-
Computed tomography and the secrets of lung nodules.Can Assoc Radiol J. 2015 Feb;66(1):2-4. doi: 10.1016/j.carj.2014.12.002. Can Assoc Radiol J. 2015. PMID: 25623006 Review. No abstract available.
Cited by
-
Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.Syst Rev. 2024 Mar 16;13(1):88. doi: 10.1186/s13643-024-02506-3. Syst Rev. 2024. PMID: 38493159 Free PMC article.
-
Applications of Machine Learning (ML) and Mathematical Modeling (MM) in Healthcare with Special Focus on Cancer Prognosis and Anticancer Therapy: Current Status and Challenges.Pharmaceutics. 2024 Feb 9;16(2):260. doi: 10.3390/pharmaceutics16020260. Pharmaceutics. 2024. PMID: 38399314 Free PMC article. Review.
-
Risk factors for early-onset lung cancer in Korea: analysis of a nationally representative population-based cohort.Epidemiol Health. 2023;45:e2023101. doi: 10.4178/epih.e2023101. Epub 2023 Nov 21. Epidemiol Health. 2023. PMID: 38037323 Free PMC article.
-
A nomogram based on metabolic profiling to discriminate lung cancer among patients with lung nodules.J Int Med Res. 2023 Mar;51(3):3000605231161204. doi: 10.1177/03000605231161204. J Int Med Res. 2023. PMID: 36974888 Free PMC article. Clinical Trial.
-
Current investigative modalities for detecting and staging lung cancers: a comprehensive summary.Indian J Thorac Cardiovasc Surg. 2023 Jan;39(1):42-52. doi: 10.1007/s12055-022-01430-2. Epub 2022 Dec 1. Indian J Thorac Cardiovasc Surg. 2023. PMID: 36590039 Free PMC article. Review.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical